Since little to nothing is known about the impact of EPO on microglia, microglial TAK1, and on the inflammasomes after stroke, we deemed an investigation of the reperfusion time point of 6 h after 30 min of tMCAo essential to draw any conclusion about a potential EPO/TAK1/inflammasome axis. The gene discussed is EPO; the disease is stroke disorder.